Leukocyte Disorders
Showing 26 - 50 of >10,000
Burns Trial in Shanghai (Cetirizine, Midazolam and Fentanyl)
Recruiting
- Burns
- Cetirizine
- Midazolam and Fentanyl
-
Shanghai, Shanghai, ChinaDepartment of Burn, Ruijin Hospital, Shanghai Jiao Tong Universi
Nov 6, 2023
Tennis Elbow Trial in Bologna (Injection of autologous leukocyte rich platelet rich plasma (LR-PRP), Injection of autologous
Recruiting
- Tennis Elbow
- Injection of autologous leukocyte rich platelet rich plasma (LR-PRP)
- +2 more
-
Bologna, ItalyIstituto Ortopedico Rizzoli
Sep 15, 2023
Apheresis of Patients With Immunodeficiency
Recruiting
- LAD-1
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Stroke, Acute, Dysphagia, Pneumonia Trial in Giza (Repetitve transcranial magnetic stimulation, Sham transcranial magnetic
Recruiting
- Stroke, Acute
- +2 more
- Repetitve transcranial magnetic stimulation
- Sham transcranial magnetic stimulation
-
Giza, Ad Doqi, Giza District, Giza Governorate, EgyptFaculty of Physical Therapy, Cairo University
Nov 7, 2023
End Stage Renal Disease Trial in Los Angeles (Tacrolimus Extended-Release Oral Capsule)
Completed
- End Stage Renal Disease
- Tacrolimus Extended-Release Oral Capsule
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jan 7, 2022
Nasal Polyps, Asthma, Aspirin-Induced, Aspirin-exacerbated Respiratory Disease Trial in Boston (Ifetroban, Placebo)
Active, not recruiting
- Nasal Polyps
- +3 more
- Ifetroban
- Placebo
-
Boston, MassachusettsAsthma Research Center, Brigham and Women's Hospital
Oct 7, 2022
Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)
Recruiting
- Metastatic Uveal Melanoma
- IDE196
- +5 more
-
Grand Rapids, MichiganThe Cancer and Hematology Centers
Aug 14, 2023
Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)
Recruiting
- Influenza A
- Pandemic Influenza
- H7HLAII
-
Oslo, NorwayOslo University Hospital
Sep 20, 2023
GVHD Trial in Tampa (Cultured Treg cells)
Completed
- Graft Versus Host Disease
- Cultured Treg cells
-
Tampa, FloridaH Lee Moffitt Cancer Center
Nov 2, 2022
Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)
Not yet recruiting
- Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
- (no location specified)
Mar 3, 2023
Leukemia, Myeloid, Acute Trial in United States (VCAR33)
Not yet recruiting
- Leukemia, Myeloid, Acute
- VCAR33
-
La Jolla, California
- +9 more
Aug 14, 2023
General Anesthesia and PECS Block Methods on Blood Counts in
Completed
- Breast Cancer
- general anesthesia
- peripheral nerve blocks
-
Ankara, Yenimahalle, TurkeyDr.Abdurrahman Yurtaslan Ankara Oncology Train and Research Hosp
Nov 21, 2023
Carcinoma, Sleep Disorder Trial in China (Yangzheng Compound Mixture, Conventional Treatment)
Recruiting
- Carcinoma
- Sleep Disorder
- Yangzheng Compound Mixture
- Conventional Treatment
-
Chongqing, Chongqing, China
- +9 more
Dec 27, 2022
Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow
Available
- Benign Neoplasm
- +3 more
- Bone Marrow Transplantation
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 9, 2021
Acute Kidney Injury, Cardiac Surgery Trial (LSALT Peptide, Placebo)
Not yet recruiting
- Acute Kidney Injury
- Cardiac Surgery
- LSALT Peptide
- Placebo
- (no location specified)
May 25, 2023
Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in
Not yet recruiting
- Ovarian Cancer
- Autologous genetically modified ADP-A2M4CD8 cells
- Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
- (no location specified)
Jan 31, 2023
Anxiety, Depression, and Rheumatoid Arthritis
Recruiting
- Rheumatoid Arthritis
- +2 more
- No intervention
-
Hangzhou, None Selected, ChinaThe Second Affiliated Hospital of Zhejiang Chinese Medical Unive
Jun 4, 2023
Complement Activation in the Lysosomal Storage Disorders
Withdrawn
- Fabry Disease
- +3 more
- Complement measurements
-
Melbourne, Victoria, AustraliaThe Royal Melbourne Hospital
Jun 2, 2021
Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)
Recruiting
- Multiple Myeloma
- APRIL-BAFF-Bicephali CAR-T cells
-
Xuzhou, Jiangsu, ChinaKailin Xu
Nov 14, 2023
Leukocyte Adhesion Deficiency Trial in Rochester (AVTX-803 (L-Fucose))
Recruiting
- Leukocyte Adhesion Deficiency
- AVTX-803 (L-Fucose)
-
Rochester, MinnesotaMayo Clinic
Aug 4, 2022
Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified
Recruiting
- Endometrial Cancer
- +8 more
- Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
-
Orlando, Florida
- +21 more
Feb 2, 2023
Immunity Disorders, Aging, Inflammation Trial in Bainbridge Island (HTB Rejuvenate)
Completed
- Immunity Disorders
- +2 more
- HTB Rejuvenate
-
Bainbridge Island, WashingtonBig Bold Health PBC
Dec 5, 2022